SAN FRANCISCO, CA, September 12, 2008 - The chairman of EUS2008 today announced that investigational research on a therapeutic technique that will allow physicians to directly inject malignant tumors with cancer fighting agents from inside the body will be presented at the 16th International Symposium of Endoscopic Ultrasonography (EUS2008) in San Francisco on September 12-13. This technique, which uses a flexible gastrointestinal endoscope with a miniature ultrasound transducer on the tip to guide a small needle directly into a tumor, could prove to be a safer and more effective approach to administering chemotherapy since it allows doctors to deliver therapy right to the tumor and avoid damaging normal surrounding tissues. Injecting drugs directly into the cancer using endoscopic ultrasound (EUS) in combination with systemic chemotherapy to kill cancer cells that have spread may prove to be a more effective approach to some cancers.
EUS combines endoscopy and ultrasound in order to obtain the most accurate, high resolution images and information about the digestive tract and the surrounding tissue and organs. A more advanced form of EUS, called curvilinear EUS, allows doctors to operate within the lumen of the gut while at the same time detect, biopsy and treat lesions and tumors that lie outside the intestinal wall. This technique is particularly useful in patients with pancreatic, esophageal and rectal cancer.
"Curvilinear endosonography will likely become the dominant technology within the field of EUS," said co-chairman of EUS2008, Robert Hawes, M.D., Professor of Medicine and Peter Cotton Chair for Endoscopic Innovation at the Medical University of South Carolina. "The potential for accurate diagnosis using ultrasound-guided biopsy, precise staging with high resolution ultrasound images and then the enormous opportunity for new therapies with the curvilinear endoscope is why we are focusing this meeting on the use of this instrumen
'/>"/>
| Contact: Lisa Koen lkoen@golinharris.com 212-373-6099 Golin/Harris International Source:Eurekalert |
Related biology news :
1. Eribulin mesylate demonstrated anti-tumor activity in patients with advanced breast cancer
2. A new radiation therapy treatment developed for head and neck cancer patients
3. St. Jude finds factors that accelerate resistance to targeted therapy in lymphoblastic leukemia
4. UC health news: molecular pathway may predict chemotherapy effectiveness
5. MIT works toward safer gene therapy
6. Intravenous gene therapy protects normal tissue of mice during whole-body radiation
7. Gene, stem cell therapy only needs to be 50 percent effective to create a healthy heart
8. Fourth Annual International Conference on Cell Therapy for Cardiovascular Diseases
9. Safe and effective therapy discovered for patients with protein-losing enteropathy
10. Ireland Cancer Center researchers advance stem cell gene therapy
11. Dolphin therapy a dangerous fad, Emory researchers warn
 |
| Copyright © 2003-2012 Bio-Medicine. All rights reserved. ABOUT | CONTACT US | DISCLAIMER | PRIVACY POLICY | TERMS AND CONDITIONS |  |